Agreement establishes direct distribution channel for customers in Japan, providing local support and expertise Partnership solidifies CN Bio’s presence in Asian markets and supports ongoing global expansion Cambridge, UK: CN Bio, a leading provider of Organ-on-a-chip (OOC) systems and solutions that accelerate drug discovery and development workflows, today announced it has entered into a strategic partnership with […]

IWATA – Yamaha Motor Co., Ltd. (Tokyo: 7272) announced today that it will exhibit the CELL HANDLER(TM) 2, a cell picking and imaging system, at SLAS2025, marking the product’s first overseas exhibition. SLAS2025, one of the world’s largest conferences and exhibitions on automation technologies in life sciences and drug discovery research, will be held in San […]

Strategic collaboration will introduce AI-enabled tools, optimized data sharing, bring your own cloud (BYOC) support, and enhanced scalability NEWTON, Mass. — The Broad Institute of MIT and Harvard today announced a strategic collaboration with Manifold, a leader in research infrastructure for biomedical science, to develop a cutting-edge research platform. This initiative expands on Broad’s vision for biomedical data analysis, secure sharing, and global […]

Cambridge, UK and Yokohama, Japan – Qkine Ltd., a specialist bioactive protein manufacturer with its core technology developed at the University of Cambridge, and REPROCELL Inc., Japan’s first and leading induced pluripotent stem cell (iPSC) company, have partnered to globally distribute high-quality proteins such as growth factors and cytokines manufactured by Qkine. Qkine has specialist expertise […]

Complementary offerings will accelerate translation of biomarkers from research to the clinic driving new growth Expanded customer relationships and continuum of solution offerings maximize cross-selling opportunities across translational, academic and pharma applications Expects to generate approximately $40 million of annual cost synergies by the end of 2026 with path to positive free cash flow generation in 2026 […]

Key Points: Esco Aster and Esco Lifesciences Group introduce the world’s first closed single-use bioreactor system, designed to meet Human and Animal Biosafety Levels (BSL) 3/4 standards for the safe culture of high-risk viruses, ensuring enhanced biosafety and containment during bioprocessing. The CelCradle® + system plays a vital role in enhancing vaccine self-sufficiency, especially in […]

Simon Egli Appointed Chief Executive Officer as Co-Founder Pascal Behr Transitions to Board of Directors Zürich, Switzerland – Cytosurge AG, a leader in single-cell manipulation, a biotech company pioneering innovative single-cell biopsies and cell-line engineering solutions, announces a leadership transition effective January 1, 2025. Pascal Behr, Ph.D., co-founder and CEO for 12 years, remains on the […]

— Nirrin Technologies, a developer of analytical tools poised to transform bioprocess analysis, today announced the founding of its Scientific Advisory Board (SAB), with key experts in diverse fields across biomanufacturing and advanced therapeutic development joining as inaugural members. The SAB will provide technical and strategic guidance for ongoing research and development programs and shape plans for […]

SAN DIEGO – Nucleus Biologics, a leader in precision cell culture media development, is proud to announce that it has achieved an industry-leading quality milestone. It has received EXCiPACT certification for Pharmaceutical Excipients and Pharmaceutical Auxiliary Materials (PAMs) and ISO 9001 certification from SGS. This Excipient GMP certification will better support the cell culture media, buffers, […]

ALAMEDA, Calif. — CellFE®, a leader in non-viral gene editing technology, and Syenex, a pioneer in enveloped delivery vectors, have announced an innovative collaboration to create a hybrid workflow that seamlessly integrates non-viral and viral approaches to cell therapy engineering. This next-generation process aims to enable streamlined workflows of complex edited cells for biotech and pharmaceutical […]